PALATIN TECHNOLOGIES, INC. Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements
PALATIN TECHNOLOGIES, INC. (PTN) reported Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements of 0 shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements · last filed 2019-05-09
- PALATIN TECHNOLOGIES, INC. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2019-03-31 was 0.00 shares.
- PALATIN TECHNOLOGIES, INC. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2018-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. incremental common shares attributable to dilutive effect of equity unit purchase agreements for the quarter ending 2018-03-31 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements 9 month |
|---|---|---|---|
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | 0.00 shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 0.00 shares 10-Q · filed 2019-02-11 | 0.00 shares 10-Q · filed 2019-02-11 | |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-09 | ||
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | 1.83M shares 10-Q · filed 2019-05-09 | |
| 2017-12-31 | 1.95M shares 10-Q · filed 2019-02-11 | 1.46M shares 10-Q · filed 2019-02-11 | |
| 2017-09-30 | 2.83M shares 10-Q · filed 2018-11-09 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-14 | 0.00 shares 10-Q · filed 2018-05-14 | |
| 2016-12-31 | 0.00 shares 10-Q · filed 2018-02-12 | 0.00 shares 10-Q · filed 2018-02-12 | |
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |